All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Filters

105 (0,07s)

Project

Transpupillary thermotherapy of occult subfoveal choroidal neovascular membrane due to age-related macular degeneration. (NK7267)

Long-term anatomical and functional results of transpupillary thermotherapy in exudative age-related macular degeneration associated with occult subfoveal choroidal neovascular membrane.......

FF - ORL, oftalmologie, stomatologie

  • 2002 - 2004
  • 4 252 tis. Kč
  • 1 060 tis. Kč
  • MZ
Project

Age related macular degeneration. Frequency, pathofysiology, therapy. (IZ2342)

9F - 9

  • 1994 - 1996
  • 248 tis. Kč
  • 372 tis. Kč
  • MZ
Project

Telerehabilitation of visually impaired seniors with macular degeneration - a comparative study of quality of life and visual functions after macular lens implantation or monocular dioptric (NU22-06-00039)

Loss of central vision (macular degeneration) at a later age reduces the quality of life, increases the risk of depression, shortens life expectancy) in developed countries. There is no causal treatment for macular dege...

Ophthalmology

  • 2022 - 2026
  • 8 871 tis. Kč
  • 8 871 tis. Kč
  • MZ
Project

"Introducing innovations for the expansion of Aireen a.s. on foreign markets" (FX05030132_7907)

"The subject of the project is the introduction of a series of innovations which, as a result, will increase by leaps and bounds competitiveness of the company and will allow Aireen to break through with a Diabetic diagnostic solution retinopathy an...

Computer sciences, information science, bioinformathics (hardware development to be 2.2, social aspect to be 5.8)

  • 2024 - 2025
  • 14 960 tis. Kč
  • 7 246 tis. Kč
  • MPO
Project

CeO2 Nanoparticles-assisted stem-based cell therapy an innovative nanopharmaceutical approach to treat retinal degenerative diseases. (TH70020001)

The main objective of CELLUX is to develop a novel pharmaceutical-based CeO2 eye drops to treat AMD (Age-related Macular Degeneration) that in combination with stem cell-based therapeutic strategies, will not only stop degenerat...

Nano-materials (production and properties)

  • 2020 - 2022
  • 3 933 tis. Kč
  • 2 348 tis. Kč
  • TA ČR
Project

Rationalization of the systemic treatment of age-related macular degeneration with rheohemapheresis (NT14037)

We proved that rheohemapheresis therapy is the only possibility of treatment of dry age-related macular degeneration. Rheohemapheresis markedly lowers certain precisely defined pathologically relevant blood high-molecular agents. It...

FF - ORL, oftalmologie, stomatologie

  • 2013 - 2015
  • 7 659 tis. Kč
  • 7 659 tis. Kč
  • MZ
Project

Proprotein convertase subtilisin/kexin 9 (PCSK9) in the pathophysiology a treatment of dry age-related macular degeneration (NV17-29241A)

in the pathogenesis of age-related macular degeneration (AMD) which is a leading cause...

FB - Endokrinologie, diabetologie, metabolismus, výživa

  • 2017 - 2020
  • 9 814 tis. Kč
  • 9 814 tis. Kč
  • MZ
Project

Influence of rheopheresis therapy on retinal function in age-related macular degeneration (NS9738)

Age-related macular degeneration (AMD) is the main cause of blindness in people over 50 years of age in industrialized countries. Rheopheresis therapy may prevent transition of the dry to devastating wet form of AMD and even improve...

FF - ORL, oftalmologie, stomatologie

  • 2008 - 2011
  • 6 543 tis. Kč
  • 6 516 tis. Kč
  • MZ
Project

Improving the quality of life in patients with stable maculopathy by implanting intraocular macula lenses and modulating visual plasticity by transcranial electrical stimulation (NV18-06-00484)

A sight loss is the most severe manifestation of the visual organ failure and it causes severity-dependent decrement in quality of life comparable to heart diseases or cancer. Macular degenerations are leading cause of legal blindne...

Otorhinolaryngology

  • 2018 - 2022
  • 7 863 tis. Kč
  • 7 863 tis. Kč
  • MZ
Project

Rheopheresis as the metod of systemic therapy in age-related macular degeneration (NR9118)

Age-related macular degeneration is the main cause of blindness in people older than 50 years in the industrialized countries. Development of its wet form progressing to disciform scar is found in 80% and results in blindness. Patho...

FF - ORL, oftalmologie, stomatologie

  • 2006 - 2008
  • 2 659 tis. Kč
  • 2 576 tis. Kč
  • MZ
  • 1 - 10 out of 105